3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prolactinoma
1
Prolactin Deficiency, Isolated
1
Hyperprolactinemia
1
Interventions
Propofol
9
Sevoflurane
7
Rituximab
7
Magnetic Resonance Spectroscopy
6
Dexamethasone
6
Trastuzumab
5
Specimen Handling
5
Enoxaparin
5
Carboplatin
5
Bevacizumab
5
Nivolumab
4
Capecitabine
4
Bupivacaine
4
trametinib
3
pirtobrutinib
3
dabrafenib
3
atezolizumab
3
apixaban
3
Lenalidomide
3
Indocyanine Green
3
Gemcitabine
3
Docetaxel
3
Cyclophosphamide
3
zanubrutinib
2
venetoclax
2
trastuzumab deruxtecan
2
ribociclib
2
polyethylene glycol 3350
2
pertuzumab
2
pembrolizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Recruiting
×
Dopamine Agonists
×
Clear all
NCT07045935
2025-09-23
ProBOLIC
University Hospital, Basel, Switzerland
Phase 4
Recruiting
60 enrolled